hypopharynx, or larynx, soft tissue sarcoma as second and third line therapy, and other solid tumors including inflammatory breast cancer. It is under development for undifferentiated pleomorphic ...

It is also under development for the treatment of advanced adrenocortical cancer, malignant pleural mesothelioma, Acral Lentiginous Melanoma, advanced/metastatic gastric cancer, metastatic esophageal ...